BFC Planning, Inc.’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.32M Sell
9,242
-334
-3% -$50.7K 0.05% 329
2026
Q2
$1.5M Sell
9,576
-138
-1% -$20.7K 0.06% 302
2026
Q1
$1.48M Buy
9,714
+725
+8% +$111K 0.07% 282
2025
Q4
$1.24M Buy
8,989
+5,115
+132% +$670K 0.05% 317
2025
Q3
$497K Sell
3,874
-404
-9% -$49.3K 0.04% 386
2025
Q2
$518K Sell
4,278
-243
-5% -$27.4K 0.04% 348
2025
Q1
$504K Sell
4,521
-1,339
-23% -$143K 0.04% 330
2024
Q4
$570K Sell
5,860
-367
-6% -$39.1K 0.05% 304
2024
Q3
$716K Buy
+6,227
New +$707K 0.06% 264

Other funds holding NVS

BFC Planning, Inc.'s NVS Position: Q3 2026 in Review

BFC Planning, Inc. reduced its Novartis (NVS) stake by 3.5% in Q3 2026, selling an estimated $50.7K and leaving 9,242 shares worth $1.32M. The position accounts for 0.05% of the portfolio, ranked #329.

BFC Planning, Inc. first reported a position in NVS in Q3 2024 and has held it in 9 quarters since. The position peaked at $1.5M in Q2 2026. 1,370 funds tracked by Wall St. Rank hold NVS as of Q3 2026.

  • BFC Planning, Inc. held 9,242 shares of Novartis worth $1.32M as of Q3 2026.
  • BFC Planning, Inc. sold 334 Novartis shares in Q3 2026, an estimated $50.7K.
  • Novartis made up 0.05% of BFC Planning, Inc.'s portfolio in Q3 2026, its #329 holding.
  • BFC Planning, Inc. first reported a position in Novartis in Q3 2024 and has held it in 9 quarters since.
  • BFC Planning, Inc.'s Novartis position peaked at $1.5M in Q2 2026.
  • 1,370 funds tracked by Wall St. Rank held Novartis as of Q3 2026.

Based on BFC Planning, Inc.'s 13F filing for Q3 2026, filed 13 Nov 2026.